Nogueira Ruchele D, Alves Alessandra C, Napimoga Marcelo H, Smith Daniel J, Mattos-Graner Renata O
Faculdade de Odontologia de Piracicaba-UNICAMP, Departamento de Microbiologia e Imunologia, Av. Limeira, 901, CEP 13414-903 Piracicaba, São Paulo, Brazil.
Infect Immun. 2005 Sep;73(9):5675-84. doi: 10.1128/IAI.73.9.5675-5684.2005.
The initial infection of children by Streptococcus mutans, the main pathogen of dental caries, depends on the ability of S. mutans to adhere and accumulate on tooth surfaces. These processes involve the adhesin antigen I/II (AgI/II), glucosyltransferases (GTF) and glucan-binding protein B (GbpB), each a target for anticaries vaccines. The salivary immunoglobulin A (IgA) antibody responses to S. mutans antigens (Ags) were characterized in 21 pairs of 5- to 13-month-old children. Pairs were constructed with one early S. mutans-infected and one noninfected child matched by age, racial background, number of teeth, and salivary levels of IgA. Specific salivary IgA antibody response and S. mutans infection levels were then measured during a 1-year follow-up. Robust responses to S. mutans were detected from 6 months of age. Salivary IgA antibody to AgI/II and GTF was commonly detected in salivas of all 42 children. However, GbpB-specific IgA antibody was seldom detected in the subset of infected children (38.1% at baseline). In contrast, most of the subset of noninfected children (76.2%) showed GbpB-reactive IgA antibody during the same period. Frequencies of GbpB responses increased with age, but differences in intensities of GbpB-IgA antibody reactions were sustained between the subsets. At baseline, GbpB-reactive IgA antibody accounted for at least half of the total salivary IgA S. mutans-reactive antibody in 33.3 and 9.5% of noninfected and infected children, respectively. This study provides evidence that a robust natural response to S. mutans Ags can be achieved by 1 year of age and that IgA antibody specificities may be critical in modulating initial S. mutans infection.
变形链球菌是龋齿的主要致病菌,儿童初次感染该菌取决于变形链球菌在牙齿表面黏附和聚集的能力。这些过程涉及黏附素抗原I/II(AgI/II)、葡糖基转移酶(GTF)和葡聚糖结合蛋白B(GbpB),它们均是抗龋疫苗的作用靶点。对21对5至13个月大的儿童的唾液免疫球蛋白A(IgA)抗体对变形链球菌抗原(Ags)的反应进行了表征。配对的儿童中,一名是早期感染变形链球菌的儿童,另一名是未感染的儿童,二者在年龄、种族背景、牙齿数量和唾液IgA水平方面相匹配。然后在1年的随访期间测量特异性唾液IgA抗体反应和变形链球菌感染水平。6个月大时就检测到了对变形链球菌的强烈反应。在所有42名儿童的唾液中均普遍检测到针对AgI/II和GTF的唾液IgA抗体。然而,在感染儿童亚组中很少检测到GbpB特异性IgA抗体(基线时为38.1%)。相比之下,在同一时期,大多数未感染儿童亚组(76.2%)显示出GbpB反应性IgA抗体。GbpB反应的频率随年龄增加,但两个亚组之间GbpB-IgA抗体反应强度的差异持续存在。在基线时,GbpB反应性IgA抗体分别占未感染和感染儿童唾液中变形链球菌反应性总IgA抗体的至少一半,比例分别为33.3%和9.5%。这项研究提供了证据,表明1岁时可实现对变形链球菌抗原的强烈自然反应,并且IgA抗体特异性可能在调节变形链球菌的初次感染中起关键作用。